Advances and prospects for subunit vaccines against protozoa of veterinary importance

Veterinary Parasitology

Volumn 101, Issue 3-4, 2001, Pages 291-310

  Jenkins, Mark C ^a  

^a AGRICULTURAL RESEARCH SERVICE   (United States)

Author keywords

Babesia; Cryptosporidium; Eimeria; Giardia; Neospora; Recombinant antigen; Theileria; Toxoplasma; Trypanosoma; Vaccine

Indexed keywords

HYPERIMMUNE GLOBULIN; MEMBRANE PROTEIN; MONOCLONAL ANTIBODY; RECOMBINANT VACCINE; TOXOPLASMA GONDII VACCINE;

ANIMAL EXPERIMENT; ARTICLE; BABESIA; COCCIDIOSIS; COLOSTRUM; CONTROLLED STUDY; CRYPTOSPORIDIOSIS; CRYPTOSPORIDIUM; DOMESTIC ANIMAL; EIMERIA; GIARDIA LAMBLIA; HOST PARASITE INTERACTION; IMMUNE DEFICIENCY; IMMUNE SYSTEM; IMMUNITY; MORBIDITY; MORTALITY; MOUSE; NEOSPORA; NONHUMAN; PARASITE VIRULENCE; PARASITOSIS; PREVENTION; PROTOZOAL INFECTION; THEILERIA ANNULATA; TOXOPLASMA; VACCINATION;

ANIMALS; ANTIGENS, PROTOZOAN; BABESIOSIS; COCCIDIOSIS; CRYPTOSPORIDIOSIS; GIARDIASIS; PROTOZOA; PROTOZOAN INFECTIONS, ANIMAL; PROTOZOAN VACCINES; THEILERIASIS; TOXOPLASMOSIS, ANIMAL; VACCINES, SUBUNIT;

EID: 0035935659     PISSN: 03044017     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-4017(01)00557-X     Document Type: Article

References (180)

1. Cysteine-rich variant surface proteins of Giardia lamblia
2. Specific cellular and humoral immune response in BALB/c mice immunized with an expression genomic library of Trypanosoma cruzi
3. Immunological control of Toxoplasma gondii and appropriate vaccine design
4. Neospora infection as a major cause of abortion in California dairy cattle
5. Evidence of vertical transmission of Neospora sp. infection in dairy cattle
6. Immunogenicity of a killed Neospora caninum tachyzoite preparation formulated with different adjuvants
7. A POLYGEN™-adjuvanted killed Neospora caninum tachyzoite preparation failed to prevent foetal infection in pregnant cattle following i.v./i.m. experimental tachyzoite challenge
8. Immunization with a DNA plasmid encoding the SAG1 (P30) protein of Toxoplasma gondii is immunogenic and protective in rodents
9. Protective immunity induced by vaccination with SAG1 gene-transfected cells against Toxoplasma gondii-infection in mice
10. Immunization against Toxoplasma gondii
11. Partially purified antigen preparation of Toxoplasma gondii protect against lethal infection in mice
12. Effect of polyclonal antisera developed against dense granule-associated Neospora caninum protein on cell invasion and development in vitro by N. caninum tachyzoites
13. Theileria parva: CD4+ helper and cytotoxic T cell clones react with a schizont-derived antigen associated with the surface of Theileria parva-infected lymphocytes
14. A novel multi-domain mucin-like glycoprotein of Cryptosporidium parvum mediates invasion
15. Interferon-γ and interleukin-12 mediate protection to acute Neospora caninum infection in BALB/c mice
16. Lysis and immobilization of Giardia muris trophozoites in vitro by immune serum from susceptible and resistant mice
17. Trypanosoma brucei infection elicits nitric oxide-dependent and nitric oxide-independent suppressive mechanisms
18. Neospora species infection in a herd of dairy cattle
19. Antigenic variation in African trypanosomes
20. Immunity and vaccine development in the bovine theilerioses
21. Different vaccine strategies used to protect against Theileria annulata
22. Theileria annulata sporozoite antigen fused to hepatitis B core antigen used in a vaccine trial
23. Vaccination of mice with the protective F3G3 antigen of Toxoplasma gondii activates CD4+, but not CD8+ T cells and induces toxoplasma specific IgG antibody
24. Designing blood-stage vaccines against Babesia bovis and B. bigemina
25. Heterogeneity in cytokine profiles of Babesia bovis-specific bovine CD4+ T cell clones activated in vitro
26. Toxoplasmosis: The first commercial vaccine
27. Cryptosporidiosis - Human and animal epidemiology
28. Molecular cloning and expression of a gene encoding Cryptosporidium parvum glycoproteins gp40 and gp15
29. Infectivity of Cryptosporidium parvum in healthy adults with pre-existing anti-C. parvum serum immunoglobulin G
30. Immunization with a plasmid DNA containing the gene of transialidase reduces Trypanosoma cruzi infection in mice
31. Designer vaccines for parasitic diseases
32. Vaccination of broilers with HVT expressing an Eimeria acervulina antigen improves performance after challenge with Eimeria
33. Molecular variation and diversity in candidate vaccine antigens from Babesia
34. Analysis of the composition of samples of Babesia bovis and the influence of different environmental conditions on genetically distinct subpopulations
35. Cloning and characterization of cDNA clones encoding two Babesia bovis proteins with homologous amino- and carboxy-terminal domains
36. Protection of mice and nude rats against toxoplasmosis by a multiple antigenic peptide construction derived from Toxoplama gondii p30 antigen
37. Intranasal immunization with SAG1 protein of Toxoplasma gondii in association with cholera toxin dramatically reduces development of cerebral cysts after oral infection
38. Speculation on whether a vaccine against cryptosporidiosis is a reality or a fantasy
39. Mechanism of killing Giardia lamblia trophozoites by complement
40. Induction of protective immunity against toxoplasmosis in mice by DNA immunization with a plasmid encoding Toxoplasma gondii GRA4 gene
41. Induction of protective immunity to Theileria annulata using two major merozoite surface antigens presented by different delivery systems
42. DNA vaccination as an approach to malaria control: Current status and strategies
43. Cell-mediated immunity in experimental Trypanosoma cruzi infection
44. Strategies to reduce transmission of Toxoplasma gondii to animals and humans
45. Neosporosis in cattle: Biology and economic impact
46. Protection of nude rats against Toxoplasma infection by excreted-secreted antigen-specific helper T cells
47. Isolation, characerization, and expression of a GRA2 homologue from Neospora caninum
48. Characterization of the effector cell that mediates cytotoxicity against Theileria parva (East Coast Fever) in immune cattle
49. The immune response to Giardia
50. The general biology of Cryptosporidium
51. Passive transfer of a monoclonal antibody specific for a sialic acid-dependent epitope on the surface of Trypanosoma cruzi trypomastigotes reduces infection in mice
52. Prospective vaccine prepared from a new mutant of Toxoplasma gondii
53. Immunization of cats with tissue cysts, bradyzoites, tachyzoites of the T-263 strain of Toxoplasma gondii
54. Babesia bovis: Dextran sulfate as an adjuvant for and precipitant of protective immunogens
55. Subcellular localization and functional characterization of Nc-p43, a major Neospora caninum tachyzoite surface protein
56. Characterization of a cDNA-clone encoding Nc-p43, a major Neospora caninum tachyzoite surface protein
57. Identification and characterization of a dense granule-associated protein in Neospora caninum tachyzoites
58. Immunization with live attenuated Salmonella dublin expressing a sporozoite protein confers partial protection against Theileria parva
59. Intestinal IgA responses to Giardia muris in mice depleted of helper T lymphocytes and in immunocompetent mice
60. Immunology of Giardia and Cryptosporidium infections
61. Clearance of Giardia muris infection requires helper/inducer T lymphocytes
62. Immunization of cattle with recombinant Babesia bovis merozoite surface antigen-1
63. Delivery of the Theileria parva p67 antigen to cattle using recombinant vaccine virus: IL-2 enhances protection
64. The p29 and p35 immunodominant antigens of Neospora caninum tachyzoites are homologous to the family of surface antigens of Toxoplasma gondii
65. Attachment of Giardia lamblia to rat intestinal epithelial cells
66. 3H uracil
67. Comparison of the humoral and cellular immune responses to two preparations of Cryptosporidium parvum CP15/60 recombinant protein
68. A Babesia bovis 225-kilodalton protein located on the cytoplasmic side of the erythrocyte membrane has sequence similarity with a region of glycogen phosphorylase
69. Eimeria tenella: Immunogenicity of arrested sporozoites in chickens
70. Progress on developing a recombinant coccidiosis vaccine
71. Development of resistance to coccidiosis in the absence of merogonic development using X-irradiated Eimeria acervulina oocysts
72. X-irradiation of Eimeria tenella oocysts provides direct evidence that sporozoite invasion and early schizont development induce a protective immune response(s)
73. Protective immunity against coccidiosis elicited by radiation-attenuated Eimeria maxima sporozoites that are incapable of asexual development
74. Cloning and expression of cDNA encoding epitopes shared by 15- and 60-kDa proteins of Cryptosporidium parvum sporozoites
75. Serum and colostrum antibody responses induced by jet-injection of sheep with DNA encoding a Cryptosporidium parvum antigen
76. Hyperimmune bovine colostrum specific for recombinant Cryptosporidium parvum antigen confers partial protection against cryptosporidiosis in immunosuppressed adult mice
77. Eimeria tenella infections in chickens: Aspects of host-parasite interaction
78. The immunity arising from continuous low-level infection with Eimeria tenella
79. The immunity arising from continuous low-level infection with Eimeria maxima and Eimeria acervulina
80. Neospora caninum: Role for immune cytokines in host immunity
81. Giardia muris adherence to intestinal epithelium - The role of specific anti-Giardia antibodies
82. Sequencing, analysis, and expression in Escherichia coli of a gene encoding a 15 kDa Cryptosporidium parvum protein
83. Responses of chickens to a recombinant refractile body antigen of Eimeria tenella administered using various immunizing strategies
84. Protective effects of specific antibodies in Trypanosoma cruzi infections
85. A 2359-base pair DNA fragment from Cryptosporidium parvum encoding a repetitive oocyst protein
86. A dense granule protein (NCDG1) gene from Neospora caninum
87. Protective effect of vaccination with a combination of recombinant surface antigen 1 and interleukin-12 against toxoplasmosis in mice
88. Isolation of the cDNA encoding a dense granule associated antigen (NCDG2) of Neospora caninum
89. Prevention of vertical transfer of Neospora caninum in BALB/c mice by vaccination
90. Avian coccidiosis: A review of acquired intestinal immunity and vaccination strategies
91. Avian gut-associated lymphoid tissues and intestinal immune responses to Eimeria parasites
92. Neutralization of maternal IL-4 modulates congenital protozoal transmission: Comparison of innate versus acquired immune responses
93. Immunization of young broiler chickens with low level infections of Eimeria tenella, Eimeria acervulina, or Eimeria maxima
94. Characterization of a cDNA encoding a subtilisin-like serine protease (NC-p65) of Neospora caninum
95. Molecular characterization of thrombospondin-related anonymous protein homologue in Neospora caninum
96. Immune responses and resistance to Toxoplasma gondii in mice immunized with antigens of the parasite incorporated into immunostimulating complexes
97. Use of recombinant antigen, SAG2, expressed as a glutathione-S-transferase fusion protein to immunize mice against Toxoplasma gondii
98. Cellular immune responses in cattle experimentally infected with Neospora caninum
99. African trypanosome infections in mice that lack the interferon-γ receptor gene: Nitric oxide-dependent and independent suppression of T-cell proliferative responses and the development of anaemia
100. Bovine babesiasis: The persistence of immunity to Babesia argentina and B. bigemina in calves (Bos taurus) after naturally acquired infection
101. Immunity in cattle to Babesia bovis after single infections with parasites of various origin
102. Eimeria tenella: Immunological diversity between asexual generations
103. Molecular characterization and immunogenicity of neutralization-sensitive Babesia bigemina merozoite surface proteins
104. Novel vaccines against Theileria parva: Prospects for sustainability
105. Adoptive transfer of immunity to Theileria parva in the CD8+ fraction of responding efferent lymph
106. Protective immune mechanisms against Theileria parva: Evolution of vaccine development strategies
107. Cytokine mRNA profiles in trypanotolerant and trypanosusceptible cattle infected with the protozoan parasite Trypanosoma congolense: Protective role for interleukin-4?
108. Trypanosoma cruzi: Protective immunity in mice immunized with paraflagellar rod proteins is associated with a T-helper type 1 response
109. Bovine babesiosis: Induction of protective immunity with culture-derived Babesia bovis and Babesia bigemina immunogens
110. Bovine immune responses to Theileria parva: Neutralizing antibodies to sporozoites
111. Evidence for a common protective antigenic determinant on sporozoites of several Theileria parva strains
112. A recombinant sporozoite surface antigen of Theileria parva induces protection in cattle
113. Subunit vaccines for the control of tick-borne diseases: Implications for the future
114. Characterization of a Giardia lamblia variant-specific surface protein (VSP) gene from isolate GS/M and estimation of the VSP gene repertoire size
115. Complete protection against lethal Toxoplasma gondii infection in mice immunized with plasmid DNA encoding the SAG1 gene
116. Monoclonal antibody inhibition of Neospora caninum tachyzoite invasion into host cells
117. Delivery of Neospora caninum surface protein, NcSRS2 (Nc-p43), to mouse using recombinant vaccinia virus
118. Immunization of dogs with a canine herpesvirus vector expressing Neospora caninum surface protein, NcSRS2
119. Prevention of vertical transmission of Neospora caninum in BALB/c mice by recombinant vaccinia virus carrying NcSRS2 gene
120. Cryptosporidium and cryptosporiosis in man and animals
121. Giardia vaccination
122. Molecular basis for vaccine development against anaplasmosis and babesiosis
123. Congenital Neospora caninum infection in dairy cattle and associated calfhood mortality
124. Comparison of antibody and protective immune responses against Trypanosoma cruzi infection elicited by immunization with a parasite antigen delivered as naked DNA or recombinant protein
125. A cloned gene of Cryptosporidium parvum encodes neutralization-sensitive epitopes
126. Protection of calves against cryptosporidiosis with immune bovine colostrum induced by a Cryptosporidium parvum recombinant protein
127. Immunization with E. coli produced recombinant T. gondii SAG1 with alum as adjuvant protect mice against lethal infection with Toxoplasma gondii
128. Innate and adaptive immune response co-operate to protect cattle against Theileria annulata
129. Cloning of the immunodominant 17-kDa antigen from Cryptosporidium parvum
130. Genetic vaccination strategies for enhanced cellular, humoral, and mucosal immunity
131. Immunology: Host response and development of passive immunotherapy and vaccines
132. Immunity to coccidiosis: Stages of the life-cycle of Eimeria maxima which induce, and are affected by, the response of the host
133. Interferon-gamma-mediated effects upon immunity to coccidial infections in the mouse
134. Gamma interferon controls Eimeria vermiformis primary infection in BALB/C mice
135. Gamma interferon-mediated inhibition of Eimeria vermiformis growth in cultured fibroblasts and epithelial cells
136. Protection of kids against Cryptosporidium parvum infection after immunization of dams with CP15-DNA
137. Nasal immunization of mice with Cryptosporidium parvum DNA induces systemic and intestinal immune responses
138. Nonspecific immune responses and mechanisms of resistance to Eimeria papillata infections in mice
139. Suppressor macrophages in African trypanosomiasis inhibit T cell proliferative responses by nitric oxide and prostaglandins
140. A live attenuated vaccine for the control of avian coccidiosis: Trials in broiler breeders and replacement layer flocks in the United Kingdom
141. Experimental Trypanosoma brucei infection selectively suppress both interleukin 2 production and interleukin-2 receptor expression
142. Interleukin 10 and interferon gamma regulation of experimental Trypanosoma cruzi infection
143. A 32 kDa surface antigen of Theileria parva: Characterization and immunization studies
144. Bovine babesiosis: Protection of cattle with culture-derived soluble Babesia bovis antigen
145. The major 36 kDa Neospora caninum tachyzoite surface protein is closely related to the major Toxoplasma gondii surface antigen
146. Molecular characterization of a novel microneme antigen in Neospora caninum
147. Cloning of the entire COWP gene of Cryptosporidium parvum and ultrastructural localization of the protein during sexual parasite development
148. Systemic and local antibody response in mice induced by a recombinant peptide fragment from Giarda lamblia variant surface protein (VSP) H7 produced by Salmonella typhimurium vaccine strain
149. Development of immunity in broilers continuously exposed to Eimeria sp.
150. Effect of in vivo T-cell depletion on the effector T-cell function of immunity to Eimeria falciformis
151. Characterization of the gene encoding a 60-kilodalton Babesia bovis merozoite protein with conserved and surface exposed epitopes
152. Immunogenicity of recombinant BCG producing the GRA1 antigen from Toxoplasma gondii
153. Distinct CD4+ T cell helper requirements in Theileria parva-immune and naïve bovine CTL precursors
154. The role of T cells in Trypanosoma cruzi infections
155. Immune response of cattle to African trypanosomes: Protective or pathogenic?
156. Immune responses of cattle infected with African trypanosomes
157. Trypanosoma congolense: B-lymphocyte responses differ between trypanotolerant and trypanosusceptible cattle
158. Development of babesial vaccines
159. Babesia bovis: Comparison of culture-derived parasites, non-living antigen, and conventional vaccine in the protection of cattle against heterologous challenge
160. Failure of a recombinant Babesia bovis antigen to protect cattle against heterologous strain challenge
161. Identification and characterization of three antigenic proteins from Cryptosporidium parvum sporozoites using a DNA library expressing poly-histidine tagged peptides
162. Immune responses against Toxoplasma and Sarcocystis infections in ruminants: Diagnosis and prospects for vaccination
163. Progress in research on tick-borne diseases: Theileriosis and heartwater
164. Role of antibody Fc in the immune clearance of Trypanosoma cruzi infections
165. Giardia intestinalis antigens expressed in Escherichia coli
166. Intranasal immunization with Toxoplasma gondii SAG1 induces protective cells into both NALT and GALT compartments
167. DNA vaccination with genes encoding Toxoplasma gondii antigens GRA1, GRA7, and ROP2 induces partially protective immunity against lethal challenge in mice
168. Recent progress in recombinant vaccine development against coccidiosis. A review and prospects into the next millenium
169. Systemic-oral immunization with 56 kDa molecule of Giardia lamblia affords protection in experimental mice
170. Simultaneous induction of multiple antigen-specific cytotoxic T lymphocytes in nonhuman primates by immunization with a mixture of four Plasmodium falciparum DNA plasmids
171. DNA vaccination strategies against infectious diseases
172. Microorganisms in the development of subunit vaccines against parasites
173. Epidemiological aspects of the use of live anticoccidial vaccines for chickens
174. The efficacy and economic benefits of Paracox, a live attenuated anticoccidial vaccine, in commercial trials with standard broiler chickens in the United Kingdom
175. Neospora caninum-associated abortion in cattle: The time of experimentally-induced parasitemia during gestation determines fetal survival
176. Identification of Trypanosoma cruzi trans-sialidase family members as targets of protective CD8+ TC1 responses
177. Vaccination with trypomastigote surface antigen 1-encoding plasmid DNA confers protection against lethal Trypanosoma cruzi infection
178. The development of a recombinant Babesia vaccine
179. Paraflagellar rod proteins administered with alum and IL-12 or recombinant adenovirus expressing IL-12 generates antigen-specific responses and protective immunity in mice against Trypanosoma cruzi
180. Protective immunity in the rat model of congenital toxoplasmosis and the potential of excreted-secreted antigens as vaccine components